Evidence map›Paper›PMID 22034515›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2012

In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.

Ahmad Y Sheikh, Bruno C Huber, Kazim H Narsinh, Joshua M Spin, Koen van der Bogt, Patricia E de Almeida, Katherine J Ransohoff, Daniel L Kraft, Giovanni Fajardo, Diego Ardigo and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Fabrication of New Hybrid Scaffolds forFrontiers in cardiovascular medicine · 2020
    Article
  5. Review
  6. ACS nano · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ahmad Y SheikhDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Bruno C Huber
Kazim H Narsinh
Joshua M Spin
Koen van der Bogt
Patricia E de Almeida
Katherine J Ransohoff
Daniel L Kraft
Giovanni Fajardo
Diego Ardigo
Julia Ransohoff
Daniel Bernstein
Michael P Fischbein
Robert C Robbins
Joseph C Wu
Research Institute of Radiology · BY

Funding

Molecular Imaging of Targeted Cardiac Gene TherapyR01HL093172 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2015
$2.7M
Nanostructuring and Molecular Imaging of Engineered Cardiovascular TissuesR33HL089027 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2011
$2.3M
Molecular Imaging of Cardiac Stem Cell TherapyR01EB009689 · NIBIB · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2010 to 2013
$1.4M
Bone Marrow Stem Cell Therapy for Ischemic Heart DiseaseF32HL084982 · NHLBI · STANFORD UNIVERSITY · PI SHEIKH, AHMAD Y · 2006 to 2007
$67k
NHLBI NIH HHS F32 HL084982NHLBI NIH HHS F32-HL-084982NHLBI NIH HHS HL093172NHLBI NIH HHS R01 HL093172NHLBI NIH HHS R33 HL089027NIBIB NIH HHS EB009689NIBIB NIH HHS R01 EB009689
6 · The paper itself

Abstract

objectiveClinical trials of bone marrow-derived stem cell therapy for the heart have yielded variable results. The basic mechanism(s) that underlies their potential efficacy remains unknown. In the present study, we evaluated the survival kinetics, transcriptional response, and functional outcome of intramyocardial bone marrow mononuclear cell (BMMC) transplantation for cardiac repair in a murine myocardial infarction model. METHODS AND

resultsWe used bioluminescence imaging and high-throughput transcriptional profiling to evaluate the in vivo survival kinetics and gene expression changes of transplanted BMMCs after their engraftment into ischemic myocardium. Our results demonstrate short-lived survival of cells following transplant, with less than 1% of cells surviving by 6 weeks posttransplantation. Moreover, transcriptomic analysis of BMMCs revealed nonspecific upregulation of various cell regulatory genes, with a marked downregulation of cell differentiation and maturation pathways. BMMC therapy caused limited improvement of heart function as assessed by echocardiography, invasive hemodynamics, and positron emission tomography. Histological evaluation of cell fate further confirmed findings of the in vivo cell tracking and transcriptomic analysis.

conclusionsCollectively, these data suggest that BMMC therapy, in its present iteration, may be less efficacious than once thought. Additional refinement of existing cell delivery protocols should be considered to induce better therapeutic efficacy.

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsCell SurvivalEchocardiographyFemaleGene Expression ProfilingGenes, ReporterHematopoietic Stem CellsHumansMaleMiceMice, TransgenicMyocardial IschemiaPositron-Emission TomographyTime Factors

Identifiers

PMID22034515
PMCPMC3241895
OpenAlexW2135188850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.